BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21548868)

  • 21. Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils.
    Watanabe T; Higuchi K; Hamaguchi M; Tanigawa T; Wada R; Tominaga K; Fujiwara Y; Arakawa T
    Dig Dis Sci; 2002 Jul; 47(7):1582-9. PubMed ID: 12141820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alendronate induces gastric injury and delays ulcer healing in rodents.
    Elliott SN; McKnight W; Davies NM; MacNaughton WK; Wallace JL
    Life Sci; 1998; 62(1):77-91. PubMed ID: 9444970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and -2.
    Brzozowski T; Konturek PC; Konturek SJ; Schuppan D; Drozdowicz D; Kwiecień S; Majka J; Nakamura T; Hahn E
    Digestion; 2001; 64(1):15-29. PubMed ID: 11549833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rebamipide reduces delay in gastric ulcer healing in cyclooxygenase-2-deficient mice.
    Watanabe T; Higuchi K; Taira K; Sasaki E; Shiba M; Tominaga K; Fujiwara Y; Oshitani N; Arakawa T
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S63-9. PubMed ID: 16184423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The cytoprotective drug rebamipide in therapy for inflammatory and erosive-ulcerative lesions of the gastrointestinal tract].
    Yakovenko EP; Agafonova NA; Ivanov AN; Yakovenko AV; Aldiyarova MA; Volosheinikova TV; Grigoryeva YV; Soluyanova IP
    Ter Arkh; 2016; 88(4):88-92. PubMed ID: 27070169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal irritative and healing impairment action of risedronate in rat stomachs: comparison with alendronate.
    Kanatsu K; Aihara E; Okayama M; Kato S; Takeuchi K
    J Gastroenterol Hepatol; 2004 May; 19(5):512-20. PubMed ID: 15086594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rebamipide solution: a novel submucosal injection material to promote healing speed and healing quality of ulcers induced by endoscopic submucosal dissection.
    Fujimoto A; Uraoka T; Nishizawa T; Shimoda M; Goto O; Ochiai Y; Maehata T; Akimoto T; Mitsunaga Y; Sasaki M; Yamamoto H; Yahagi N
    Gastrointest Endosc; 2018 Apr; 87(4):1114-1120. PubMed ID: 28993136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action?
    Tarnawski AS; Chai J; Pai R; Chiou SK
    Dig Dis Sci; 2004 Feb; 49(2):202-9. PubMed ID: 15104358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study.
    Shin WG; Kim SJ; Choi MH; Kim KO; Jang HJ; Park CH; Baek IH; Kim KH; Baik GH; Kae SH; Kim JH; Kim HY
    Gastrointest Endosc; 2012 Apr; 75(4):739-47. PubMed ID: 22281110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori.
    Thong-Ngam D; Chayanupatkul M; Klaikeaw N; Rerknimitr R; Mahachai V
    J Med Assoc Thai; 2009 Sep; 92(9):1207-12. PubMed ID: 19772181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study.
    Naito Y; Yoshikawa T; Iinuma S; Yagi N; Matsuyama K; Boku Y; Fujii T; Yoshida N; Kondo M; Sasaki E
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):83S-89S. PubMed ID: 9753232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis.
    Ishihara T; Tanaka K; Tashiro S; Yoshida K; Mizushima T
    Biochem Pharmacol; 2010 Jun; 79(11):1622-33. PubMed ID: 20132796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Healing promoting effect of proamipide, a novel drug that increases gastric defense mechanisms, on acetic acid-induced gastric ulcers in the rat].
    Shiraki M; Yamasaki K; Ishiyama H; Kanbe T; Yabuuchi Y; Asada S; Hirata I; Ooshiba S
    Nihon Yakurigaku Zasshi; 1988 Dec; 92(6):389-95. PubMed ID: 2855070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.
    Terano A; Arakawa T; Sugiyama T; Suzuki H; Joh T; Yoshikawa T; Higuchi K; Haruma K; Murakami K; Kobayashi K;
    J Gastroenterol; 2007 Aug; 42(8):690-3. PubMed ID: 17701133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipide.
    Haruma K; Ito M
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():153-9. PubMed ID: 12925154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ulcerogenic and healing impairing actions of monochloramine in rat stomachs: effects of zinc L-carnosine, polaprezinc.
    Nishiwaki H; Kato S; Sugamoto S; Umeda M; Morita H; Yoneta T; Takeuchi K
    J Physiol Pharmacol; 1999 Jun; 50(2):183-95. PubMed ID: 10424716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic effect of rebamipide on ammonia-induced gastric mucosal hemorrhagic lesion in rats.
    Huh K; Kwon TH; Kim SK; Kim JS; Shin US
    Arch Pharm Res; 1998 Feb; 21(1):1-5. PubMed ID: 9875506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of endogenous basic fibroblast growth factor in the healing of gastric ulcers in rats.
    Satoh H; Shino A; Sato F; Asano S; Murakami I; Inatomi N; Nagaya H; Kato K; Szabo S; Folkman J
    Jpn J Pharmacol; 1997 Jan; 73(1):59-71. PubMed ID: 9032135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Quality of ulcer healing and rebamipide].
    Fujiwara Y; Higuchi K; Tominaga K; Watanabe T; Arakawa T
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():397-400. PubMed ID: 16363567
    [No Abstract]   [Full Text] [Related]  

  • 40. Rebamipide induces the gastric mucosal protective factor, cyclooxygenase-2, via activation of 5'-AMP-activated protein kinase.
    Lee S; Jeong S; Kim W; Kim D; Yang Y; Yoon JH; Kim BJ; Min DS; Jung Y
    Biochem Biophys Res Commun; 2017 Jan; 483(1):449-455. PubMed ID: 28011266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.